Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0U3GL
|
||||
Former ID |
DAP000905
|
||||
Drug Name |
Oxandrolone
|
||||
Synonyms |
Anavar; Lonavar; Ossandrolone; Oxandrin; Oxandrolona; Oxandrolonum; Protivar; Provitar; Vasorome; Ossandrolone [DCIT]; SC 11585; Anavar (TN); Oxandrin (TN); Oxandrolona [INN-Spanish]; Oxandrolonum [INN-Latin]; SC-11585; Oxandrin, Anavar, Oxandrolone; Oxandrolone (JAN/USP/INN); Oxandrolone [USAN:INN:BAN:JAN]; Dodecahydro-3-hydroxy-6-(hydroxy-methyl)-3,3a,6-trimethyl-1H-benz(e)indene-7-acetic acid delta-lactone; (1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one; (4aS,4bS,6aS,7S,9aS,9bR,11aS)-7-hydroxy-4a,6a,7-trimethyltetradecahydroindeno[4,5-h]isochromen-2(1H)-one; 17-beta-hydroxy-17-methyl-2-oxa-androstan-3-one; 17-beta-hydroxy-17-methyl-2-oxa-androstan-3-one (9CI); 17beta-Hydroxy-17-methyl-2-oxa-5alpha-androstan-3-one; 17beta-Hydroxy-17alpha-methyl-2-oxa-5alpha-androstan-3-one; 2-Oxa-5alpha-androstan-3-one, 17beta-hydroxy-17-methyl-(8CI); 2-Oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5-alpha,17-beta)-(9CI)
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Pfizer Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H30O3
|
||||
InChI |
InChI=1S/C19H30O3/c1-17-11-22-16(20)10-12(17)4-5-13-14(17)6-8-18(2)15(13)7-9-19(18,3)21/h12-15,21H,4-11H2,1-3H3/t12-,13+,14-,15-,17-,18-,19-/m0/s1
|
||||
InChIKey |
QSLJIVKCVHQPLV-PEMPUTJUSA-N
|
||||
CAS Number |
CAS 53-39-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9553, 7847528, 7980213, 8153633, 14751988, 14776396, 29224905, 46509027, 48416358, 49833409, 49999542, 56310882, 56313001, 56352998, 57323011, 71821462, 78468418, 92713867, 103770419, 104253360, 104310507, 119525274, 124757478, 125164282, 126629716, 126665869, 129068737, 134222231, 134338182, 134971185, 137003785, 140181114, 160963966, 170506535, 175266129, 175611735, 176485087, 178103670, 179117105, 196110073, 210279824, 210282147, 223672704, 223813099, 226514498, 241093246, 252159083, 252220166, 252451761
|
||||
ChEBI ID |
ChEBI:7820
|
||||
SuperDrug ATC ID |
A14AA08
|
||||
SuperDrug CAS ID |
cas=000053394
|
||||
Target and Pathway | |||||
Target(s) | Androgen receptor | Target Info | Agonist | [536376] | |
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Coregulation of Androgen receptor activity | |||||
Regulation of Androgen receptor activity | |||||
Nongenotropic Androgen signaling | |||||
Regulation of nuclear beta catenin signaling and target gene transcription | |||||
FOXA1 transcription factor network | |||||
Notch-mediated HES/HEY network | |||||
References | |||||
Ref 538317 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 076761. | ||||
Ref 542098 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7092). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.